Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
buprenorphine (2 trials)
naloxone (narcan) (2 trials)
Heroin Dependence (Phase 3)
Morphine Dependence (Phase 3)
Substance Withdrawal Syndrome (Phase 3)
Trials (2 total)
Trial APIs (2 total)